Novanta Inc is a global provider of advanced technology solutions that cater to the medical and advanced industrial markets
The company specializes in the design and manufacturing of photonics, motion, and precision optics systems, which are critical in enabling precise and efficient functioning of various applications, such as surgical equipment, laser-based technologies, and automated industrial processes. With a focus on innovation and quality, Novanta works closely with its customers to develop tailored solutions that enhance performance and reliability in demanding environments, ultimately contributing to improved outcomes in healthcare and productivity across various industries.
Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its fourth quarter and full year 2024 results on Tuesday, February 25, 2025.
Over the last six months, Novanta’s shares have sunk to $149.65, producing a disappointing 17.7% loss - a stark contrast to the S&P 500’s 12.6% gain. This was partly driven by its softer quarterly results and may have investors wondering how to approach the situation.
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Bel Fuse (NASDAQBELFA) and the best and worst performers in the electronic components industry.
As the Q3 earnings season wraps, let’s dig into this quarter’s best and worst performers in the electronic components industry, including Allient (NASDAQALNT) and its peers.
As the Q3 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the electronic components industry, including Littelfuse (NASDAQLFUS) and its peers.
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q3. Today, we are looking at electronic components stocks, starting with Vishay Precision (NYSEVPG).
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q3. Today, we are looking at electronic components stocks, starting with Novanta (NASDAQNOVT).
As the Q3 earnings season wraps, let’s dig into this quarter’s best and worst performers in the electronic components industry, including Vicor (NASDAQVICR) and its peers.
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at nLIGHT (NASDAQLASR) and the best and worst performers in the electronic components industry.
Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that management will be participating at the CJS Securities 25th Annual New Ideas for the New Year Investor Conference on Tuesday, January 14, 2025, which is being held virtually.
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Advanced Energy (NASDAQAEIS) and the rest of the electronic components stocks fared in Q3.
Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Matthijs Glastra, Chair & Chief Executive Officer, and Robert Buckley, Chief Financial Officer, are scheduled to present at the J.P. Morgan 43rd Annual Healthcare Conference on Monday, January 13, 2025, in San Francisco, California.
As the Q3 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the electronic components industry, including Corning (NYSEGLW) and its peers.
As the Q3 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the electronic components industry, including Knowles (NYSEKN) and its peers.
Medicine and manufacturing technology provider Novanta (NASDAQNOVT) met Wall Street’s revenue expectations in Q3 CY2024, with sales up 10.3% year on year to $244.4 million. On the other hand, next quarter’s revenue guidance of $239.5 million was less impressive, coming in 9.3% below analysts’ estimates. Its GAAP profit of $0.53 per share was 3.6% below analysts’ consensus estimates.
Novanta Inc. (Nasdaq: NOVT) (“Novanta” or the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, today reported financial results for the third quarter 2024.
Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Matthijs Glastra, Chair & Chief Executive Officer is scheduled to present at the Baird 2024 Global Industrial Conference on Wednesday, November 13, 2024, in Chicago, Illinois.
Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its third quarter 2024 results on Tuesday, November 5, 2024.
Novanta Inc. (Nasdaq: NOVT) (“Novanta” or the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, today reported financial results for the second quarter 2024.
Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Matthijs Glastra, Chair & Chief Executive Officer, is scheduled to present at Baird's 2024 Global Healthcare Conference on Tuesday, September 10, 2024, in New York, NY.
